• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    CL King initiated coverage on Axonics Modulation with a new price target

    5/23/23 7:23:40 AM ET
    $AXNX
    Medical/Dental Instruments
    Health Care
    Get the next $AXNX alert in real time by email
    CL King initiated coverage of Axonics Modulation with a rating of Buy and set a new price target of $75.00
    Get the next $AXNX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AXNX

    DatePrice TargetRatingAnalyst
    1/9/2024Outperform → Peer Perform
    Wolfe Research
    7/19/2023$69.00Outperform
    Robert W. Baird
    7/13/2023$70.00Overweight
    KeyBanc Capital Markets
    5/23/2023$75.00Buy
    CL King
    4/14/2023$75.00Buy
    Mizuho
    3/24/2023$71.00Hold → Buy
    Needham
    10/21/2022$85.00Outperform
    RBC Capital Mkts
    10/12/2022$75.00Hold
    Jefferies
    More analyst ratings

    $AXNX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Axonics Modulation downgraded by Wolfe Research

      Wolfe Research downgraded Axonics Modulation from Outperform to Peer Perform

      1/9/24 6:49:41 AM ET
      $AXNX
      Medical/Dental Instruments
      Health Care
    • Robert W. Baird initiated coverage on Axonics Modulation with a new price target

      Robert W. Baird initiated coverage of Axonics Modulation with a rating of Outperform and set a new price target of $69.00

      7/19/23 7:13:39 AM ET
      $AXNX
      Medical/Dental Instruments
      Health Care
    • KeyBanc Capital Markets initiated coverage on Axonics Modulation with a new price target

      KeyBanc Capital Markets initiated coverage of Axonics Modulation with a rating of Overweight and set a new price target of $70.00

      7/13/23 7:29:51 AM ET
      $AXNX
      Medical/Dental Instruments
      Health Care